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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYLineage tracing usingCre/lox transgenicmice provides a powerful tool for studying normalmammary epithelial cell (MEC) development
and the cellular origins ofmammary tumors under physiological settings. However, generation of new transgenicmice for lineage-tracing
purposes is often time consuming. Here, we report a lineage-tracing tool for MECs based on intraductal injection of lineage-specific Cre-
expressing adenovirus (Ad-Cre). Usingwell-characterized promoters forKeratin 8 andKeratin 14, we generated lineage-specificAd-Cre lines
for luminal and basal MECs, respectively. By pulse-chase lineage tracing using these Ad-Cre lines, we showed that luminal and basal lin-
eages are largely self-sustained and that IRS1 and IRS2 are essential for maintaining the basal lineage; we also showed that heterogeneous
mammary tumors can be induced from luminal MECs in mice carrying the Etv6-NTRK3 fusion gene. Overall, we validated the Ad-Cre
system as a promising and efficient tool for fate mapping of normal and malignant cells in adult tissues.INTRODUCTION
Lineage tracing is a powerful tool for studying tissue devel-
opment, homeostasis, and disease, and has provided un-
precedented insights into stem cell biology (Kretzschmar
and Watt, 2012). Previous lineage-tracing studies mostly
relied on inducible Cre-estrogen receptor fusion protein
(CreER)-expressing transgenic mice upon induction by
tamoxifen. This inducible system was recently used for
fate-mapping studies of mammary epithelial cells (MECs)
under the physiological setting (Lafkas et al., 2013; Rios
et al., 2014; Sale et al., 2013; van Amerongen et al., 2012;
Van Keymeulen et al., 2011). However, wider application
of this approach is limited by several factors. First, the
choice of specific inducible CreER-expressing lines is often
limited, and generating new mouse lines for this purpose
can be time consuming. Second, most CreER mice do not
target MECs exclusively, and for breast cancer modeling
studies, their activities outside of the mammary gland
(MG)may lead to systematic deficiency or unwanted tumor
induction in other tissues, which could limit their use for
studying MECs. Third, administration of tamoxifen may
interfere with development of hormone-dependent tu-
mors (e.g., mammary tumors), as well as normal MG devel-
opment (Rios et al., 2014). Lastly, recent studies showed
that the tamoxifen doses commonly used to induce Cre/
lox recombination in mice might continue to label signifi-
cant numbers of cells for weeks after tamoxifen treatment
(Reinert et al., 2012) and that tamoxifen could change
the behavior of stem cells (Zhu et al., 2013), both of which
could affect interpretation of results from lineage-tracing
experiments.770 Stem Cell Reports j Vol. 2 j 770–779 j June 3, 2014 j ª2014 The AuthorAdenovirus is a DNA virus, and it does not integrate
into the host genome. It can infect both dividing and
nondividing cells, leading to transient high-level protein
expression (Anderson et al., 2000). Intraductal injection of
adenovirus was previously shown to be an efficient way to
transduce genes in MECs (Russell et al., 2003). Cre-express-
ing adenovirus (Ad-Cre) under the control of the constitu-
tive CMV promoter (Ad-CMV-Cre) has been successfully
used to induce cancer development in multiple organs
(e.g., lung, ovary, and bladder; [DuPage et al., 2009;
Flesken-Nikitin et al., 2003; Puzio-Kuter et al., 2009]).
Recently, Sutherlandet al. (2011)usedcell-type-specificpro-
moters andAd-Cre to initiate small cell lung cancer develop-
ment from different subsets of lung cells. We hypothesized
that, similarly to the inducible CreER system, transient
expression of Cre from adenoviral vectors could offer a tem-
poral and spatial genetic-marking system for pulse-chase
lineage-tracing studies in adult cells. In this study, we tested
this approach in theMGbygeneratingMEC lineage-specific
Ad-Cre lines, and demonstrated that they can be used for
MEC fate-mapping, gene loss-of-function, and cancer-in-
duction studies in the native environment. This approach
should also be suitable for lineage-tracing studies in other
systems in which introduction of Ad-Cre is feasible.RESULTS AND DISCUSSION
Genetic Marking of MECs by Intraductal Injection of
Ad-Cre
It was demonstrated previously that mammary epithelium
could be effectively transduced in vivo by adenovirus vias
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this procedure successfully inMGs of both adult virgin (Fig-
ure 1A) and 3-week-old (Figure 1B) female mice. Since pu-
berty in mice occurs at 4–6 weeks of age, this approach
should allow us to introduce genetic changes into MECs
during both pubertal development and adulthood. In pilot
experiments,we injectedAd-CMV-Cre into #4MGsof a con-
ditional Cre-reporter mouse line, Rosa26-lsl-YFP (R26YFP).
Cre expression from adenovirus triggered the excision of a
floxed Stopper cassette in the R26YFP knockin allele, leading
to permanent genetic marking of the infected cells and
their progeny by yellow fluorescent protein (YFP; Figures
1C and 1D). The labeling efficiency of MECs, as measured
by the percentage of YFP+ cells 3 days after injection, ranged
from 0.65% ± 0.05% to 19.23% ± 4.85%, corresponding to
titers of Ad-CMV-Cre from 107 to 109 pfu/ml (Figure 1E). All
majorMEC subpopulations, includingmature luminal cells
(MLs, CD31CD45TER119(Lin)CD24hiCD29+CD61),
luminal progenitors (LPs, LinCD24hiCD29+CD61+), and
basal cells (LinCD24medCD29hi), could be effectively
labeled (Figure 1F). Only very minimal YFP-marked cells
were detected in the stromal gate, which suggests that little
viral leakage occurred, thus enabling us to study cell-
autonomous effects in MECs (Figure 1F). Since the needle
used for injection might have come in contact with skin
surrounding the nipple, we performed immunofluores-
cence (IF) staining of tissues in this area. We only detected
YFP+ cells in the mammary ducts directly adjacent to
the skin, as well as a few YFP+ stromal cells; no skin
cells were found to be YFP+ (Figure S1A available online).
Using flow cytometry and PCR for genomic DNA, we did
not detect Cre-mediated excision in the R26YFP allele
in tissues outside of the MG (Figures S1B–S1D), further
confirming the MEC specificity of this approach. Lastly,
since it was reported that intratracheal administration
of Ad-Cre to the mouse lung could lead to clearance of
infected lung cells, possibly due to an immune response
(Meuwissen et al., 2001), we checked mammary tissues at
various time points after intraductal injection of Ad-Cre.
We did not observe any significant inflammatory response
(Figure S1E), consistent with a previous study (Russell
et al., 2003).
To assess the transient expression nature of adenovirus
in vivo, we measured the duration of adenovirus-mediated
gene expression in MECs by intraductally injecting CMV-
GFP adenovirus (Ad-CMV-GFP) into wild-type FVB females.
We found that at day 2 postinjection, 14.77% ± 4.60%
GFP+ cells were detected in the injected MGs; this number
quickly dropped to 3.70% ± 1.48% at 1week after injection,
and to zero at 2 weeks postinjection (Figure 1G). We reason
that Cre expression from the same adenoviral system
should follow a similar kinetics and thus serves a similar
purpose as the inducible CreER mice.SteMEC Lineage Tracing Using Cell-Type-Specific Ad-Cre
Lines
To target different MEC subsets, we generated lineage-spe-
cific Ad-Cre lines by using the same adenoviral backbone
as Ad-CMV-Cre coupled with a cell-type-specific promoter
to drive nlsCre (nls: nuclear localization sequence) expres-
sion. For the luminal lineage, we used the mouse Keratin 8
(K8) promoter (Van Keymeulen et al., 2011) and generated
Ad-K8-nlsCre virus. Three days after Ad-K8-nlsCre injection
into R26YFP females, we found that Ad-K8-nlsCre specif-
ically led to YFP labeling of luminal MECs (Figure 2Ab),
including both MLs and LPs (Figure 2Ad). By IF staining
of sorted YFP+ cells or MG sections from the injected
R26YFP females, we confirmed that the YFP+ cells were
exclusively K8+K14 luminal cells (Figures 2C and S2D).
To test the long-term labeling efficiency, we chased
R26YFP females injected with Ad-K8-nlsCre for 1.5 months.
At this stage, we found that YFP+ cells could still be detected
robustly and all YFP+ cells remained restricted to the
luminal gate (Figure 2Af). A similar observation was made
even when the injected mice were chased further to
6 months (Figure S2A). These data suggest that the K8+
luminal lineage contains self-sustained, long-lived MECs.
Next, Ad-K8-nlsCre-injected R26YFP females were bred to
trigger alveolar differentiation. At midgestation, we found
that Ad-K8-nlsCre-marked YFP+ luminal cells contributed
to luminal cells in both lobules and main collecting ducts
(Figures 2D and S2B). A previous in vivo lineage-tracing
study using K8-CreERT2 mice showed that in adult MGs,
the luminal and basal lineages were maintained by their
own unipotent stem cells (Van Keymeulen et al., 2011).
Although a more recent lineage-tracing study provided
evidence for a contribution of bipotent basal stem cells
to the luminal lineage in vivo, it also revealed long-lived
LPs that could contribute to maintenance of the luminal
lineage (Rios et al., 2014). The results fromourAd-K8-nlsCre
approach agreed with these findings, showing that the
luminal lineage, including both ductal and alveolar
luminal cells, could be self-sustained by luminal lineage-
restricted stem cells or long-lived progenitors.
To mark the basal lineage, we used the human Keratin 14
(K14) promoter to direct nlsCre expression via adenovirus
(Ad-K14-nlsCre) (Sugihara et al., 2001). By intraductally in-
jecting Ad-K14-nlsCre into R26YFP females, we found that
most YFP+ cells were restricted to the basal gate; however,
a small population of YFP+ cells could also be detected in
the luminal gate (Figure 2Bb). Upon a long-term chase
(1.5 months), we found that Ad-K14-nlsCre-marked YFP+
basal and luminal cells were both maintained (Figure 2Bf).
To determine the identities of the YFP+ cells, we sorted YFP+
cells in the luminal or basal gate from R26YFP females
3 days after Ad-K14-nlsCre injection, and stained them for
K8 and K14. We found that YFP+ cells sorted from the basalm Cell Reports j Vol. 2 j 770–779 j June 3, 2014 j ª2014 The Authors 771
Figure 1. Genetic Marking of MECs by Intraductal Injection of Ad-Cre
(A and B) Intraductal injection of trypan blue dye into adult (A) and 3-week-old (B) female mice.
(C) Schematic diagram of R26YFP reporter activation upon Cre-mediated excision of a floxed Stopper (Stop) cassette.
(D) Schematic diagram of lineage-tracing strategy using intraductal injection of Ad-Cre. Green star designates a YFP-marked stem cell;
other green cells refer to more differentiated MECs.
(E) Different efficiencies of Cre-mediated recombination (measured as % YFP+ cells) achieved by using different titers of Ad-CMV-Cre.
(F) Flow-cytometric analysis of R26YFP females 3 days after Ad-CMV-Cre intraductal injection. Luminal cells (Lu), including luminal pro-
genitors (LP) and mature luminal cells (ML), and basal/myoepithelial cells (Ba), including mammary stem cells (MaSCs), can be labeled by
YFP upon Ad-Cre induction. Very few stromal cells (S) were labeled by this approach.
(G) Intraductal injection of Ad-CMV-GFP into FVB mice showing transient GFP expression in MGs. In (E) and (G), n = 3 (injected MGs). Data
were reported as mean ± SEM.
See also Figure S1.
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contrast, the smaller subpopulation of YFP+ cells sorted
from the luminal gate were entirely K8+K14, suggesting
that a small portion of luminal cells were indeed labeled
by Ad-K14-nlsCre (Figure S2F). Next, R26YFP females were
markedbyAd-K14-nlsCre at thenulliparous stage and either
remained virgins orwent throughpregnancy. By IF staining
of their MG sections, we found that Ad-K14-nlsCre-marked
basal cells contributed to both alveolar and ductal basal/
myoepithelial cells (Figures 2E, 2F, and S2C). A small
portion of YFP+ MECs induced by Ad-K14-nlsCre also
contributed to lobular and ductal luminal cells (Figure 2G).
To determine the cellular origins of these labeled luminal
cells, we performed a detailed clonal analysis (Figures 2H
and S2G–S2J). We counted YFP+ clones in the injected
MGs at 3 days, 3 weeks, and 7 weeks after Ad-K14-nlsCre in-
jection, and classified them into three categories: K14-only
clones (K14+K8), K8-only clones (K8+K14), and mixed
clones containing both cell types. We found that generally,
K14+ clones and K8+ clones were labeled independently
of each other (Figures 2H and S2G). Upon a 7-week chase,
70% K14-only basal clones, 20% K8-only luminal clones,
and 10% mixed clones were observed (Figure S2G). These
data, combined with those obtained from Ad-K8-nlsCre-
based lineage tracing, suggest that the K14+ basal lineage
is also self-sustained and may not contribute significantly
to the luminal lineage in the short term. However, our
data (e.g., showing the presence of mixed clones and a
slight increase in the percentages of K8-only and mixed
multicell clones upon a 7-week chase; Figure 2H) also do
not exclude the possibility that rare K14+ basal MECs can
make a long-term contribution to the luminal lineage un-
der the physiological setting, as demonstrated recently
(Rios et al., 2014). Since the mixed clones we observed
may also have resulted from the fusion of two indepen-
dently labeled basal and luminal clones that were in a close
proximity, three-dimensional analyses at much lower
clonal densities will be required before we can precisely
assess the cellular origin of these putative mixed clones.
IRS1 and IRS2 Are Essential for Maintaining the Basal
Lineage
To determine whether lineage-specific Ad-Cre can be used
to study the cell-autonomous function of genes or
signaling pathways, we used Ad-K8-nlsCre and Ad-K14-
nlsCre to study the role of insulin growth factor/insulin re-
ceptor substrate (IGF/IRS) signaling in adult MECs. During
development, the IGF pathway is a primarymediator of the
Growth Hormone pathway, which stimulates terminal end
bud formation and ductal elongation (Kelly et al., 2002;
Kleinberg and Ruan, 2008). Intracellular transduction
of IGF and Insulin signaling are both mediated by two
adaptor proteins, IRS1 and IRS2, through tyrosine phos-Stephorylation (Dearth et al., 2007; Heckman et al., 2007).
Abnormal activation of IGF signaling is closely associated
with increased breast cancer risk (de Ostrovich et al., 2008).
Both IRS1 and IRS2were previously shown to play impor-
tant roles during embryonic MG development (Chan and
Lee, 2008; Heckman et al., 2007). Postnatally, both Irs1
and Irs2 null MGs are normal, possibly because they
compensate for each other (Chan and Lee, 2008; Heckman
et al., 2007). We previously generated Irs1/Irs2 double
conditional knockout mice with the R26YFP reporter
(Irs1L/L;Irs2L/L;R26YFP) and used K14-Cre and MMTV-Cre
mouse lines to disrupt them in MECs (Figure S3A).
Although the MGs of these mice looked largely normal
by both histological (Figure S3B) and flow-cytometric
(Figure S3C) analyses, by characterizing the LinYFP+ cells
(i.e., Irs1/2 null cells), we found that bothmodels exhibited
significantly reduced percentages of LinYFP+ Irs1/2 null
cells (Figures S3C and S3D), suggesting a growth defect
of Irs1/2 double-knockout MECs. In particular, in the
K14-Cre model, which induced Irs1/2-loss in a lot more
basal cells than the MMTV-Cre model, disruption of
IGF/IRS signaling dramatically reduced the percentage of
LinYFP+ basal cells (Figures S3C and S3E), suggesting
that the basal lineage may be more dependent on this
pathway for its survival and/or proliferation than luminal
cells. However, since both K14 and MMTV promoters are
also active during embryonic development, one cannot
differentiate the effects of Irs1/2 loss on embryonic MEC
development from those of adult MECmaintenance by us-
ing conventional K14-Cre or MMTV-Cre mice.
To determine whether IGF/IRS signaling is required for
maintenance of each MEC lineage in adults, we injected
Ad-K8-nlsCre or Ad-K14-nlsCre into adult Irs1L/L;Irs2L/L;
R26YFP nulliparous females. Three days after injection, we
found that the Irs1L/L;Irs2L/L;R26YFP mice showed similar
YFP-labeling efficiencies compared with R26YFP-only con-
trol females (Figures 3A and 3B). However, 3 weeks after
injection, whereas a similar level of YFP+ cells (compared
with the initial labeling) could be detected in R26YFP
control females, in Irs1L/L;Irs2L/L;R26YFP females, the per-
centages of YFP+ cells induced by either Ad-K8-nlsCre or Ad-
K14-nlsCre injection decreased significantly (Figures 3A–
3C). These data suggest that IGF/IRS signaling is also essen-
tial for maintaining the homeostasis of both the luminal
and basal lineages in adult MGs. We also noted that Ad-
K14-nlsCre-labeled YFP+ basal cells almost completely disap-
peared after 3 weeks (Figure 3C, compare red circle in p with
those in l and n), whereas a fewAd-K14-nlsCre-labeled orAd-
K8-nlsCre-labeled YFP+ luminal cells were still present after a
3-week chase (Figure 3C, compare green circles inhor pwith
those in d and f, or in l and n, respectively). These data agree
with our findings from the K14-Cre and MMTV-Cre condi-
tional knockout mice, and suggest that basal cells are morem Cell Reports j Vol. 2 j 770–779 j June 3, 2014 j ª2014 The Authors 773
(legend on next page)
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essential for maintaining the basal lineage in vivo. Taken
together, these results show that the lineage-specific Ad-Cre
system enabled us to quickly study the functions and
interactions of different genes and signaling pathways in a
cell-autonomous manner.
Studying the Cellular Origin of Mammary Tumors by
Using Lineage-Specific Ad-Cre
Since Sutherland et al. (2011) were able to initiate small cell
lung cancer using Ad-Cre, we hypothesized that our cell-
lineage-specific Ad-Cre viruses would allow us to study the
cellular origin and transformation process of mammary
tumorigenesis. To test this, we injected Ad-K8-nlsCre into
the mammary ducts of mice carrying the Etv6-NTRK3
(EN) conditional knockin allele we generated previously
(Li et al., 2007). EN fusion oncogene, a product from
t(12;15)(p13;q25) chromosome translocation, produces a
chimeric tyrosine kinase that is characteristic of human
secretory breast carcinoma (Tognonet al., 2002). Previously,
commonly used MEC-specific Cre-expressing mouse lines,
including MMTV-Cre, K14-Cre, and Wap-Cre, were applied
to activate EN expression. However, due to activity outside
of the MGs, MMTV-Cre or K14-Cre-driven EN activation
led to animal lethality before any mammary tumor devel-
oped. Only Wap-Cre successfully induced activation of EN
in alveolar progenitors inMGs, leading to the development
ofmammary tumorswith 100%penetrance (Li et al., 2007).
We utilized Ad-K8-nlsCre for tumor induction in EN/+
females through intraductal injection. In all injected
EN/+ mice, we did not detect any complication or malig-
nancy in other tissues outside of the MG, including skin
surrounding the injected nipple area. All injected EN/+
females developed multifocal mammary tumors in the
injected glands with a tumor-free latency similar to that
observed inWap-Cre;EN females (Figure 4A). Cre-mediated
activation of the EN knockin allele (i.e., removal of a floxed
Stopper cassette) was confirmed by PCR using tumor
genomic DNA (Figures 4B and S4A), suggesting that theFigure 2. MEC Lineage Tracing Using Cell-Type-Specific Ad-Cre Lin
(A) Ad-K8-nlsCre specifically labeled luminal epithelial cells (Lu), inclu
(a–d) and 1.5 months (e–h) after injection.
(B) Ad-K14-nlsCre-labeled cells were mostly basal/myoepithelial cell
injection. A small portion of luminal cells were also labeled by Ad-K1
(C–G) IF staining of MGs after various chase durations for YFP+ MECs
(C) Nulliparous MG 3 weeks after Ad-K8-nlsCre injection.
(D) Midgestation MG after Ad-K8-nlsCre injection. Ad-K8-nlsCre-induce
(E) Nulliparous MG 3 weeks after Ad-K14-nlsCre injection.
(F and G) Midgestation MGs after Ad-K14-nlsCre injection. Ad-K14-nlsC
and both ductal and alveolar luminal cells (G). Scale bars, 50 mm.
(H) YFP-marked multicell clones (at least three cells per clone) indu
patterns were quantified as K8-only clones, K14-only clones, or mixe
See also Figure S2.
Stedevelopment of mammary tumors was indeed driven by
EN. IF staining of the induced tumors for K8 and K14
showed that two tumor types that developed in the previ-
ous Wap-Cre;EN model (Li et al., 2007) were recapitulated
in the injected females, including type 1 tumors composed
of K8+ luminal tumor cells surrounded by K14+K5+ basal tu-
mor cells (‘‘bilineage,’’ 7 out of 14 tumors), and a type 2 less
differentiated tumor comprised of K8+K14+K5 cells (‘‘dou-
ble positive,’’ 1 out of 14) (Figures 4C and S4B). Interest-
ingly, in the injected females, a new type of tumor (type
3 ‘‘luminal,’’ 6 out of 14; Figures 4C and S4B) consisting
of predominantly K8+K14K5 luminal tumor cells was
also detected. All of these tumors were negative or weakly
positive (e.g., type 1) for estrogen receptor (Figure S4B).
In virgin females, Wap-Cre (either from the transgenic
mouseor viaadenovirus) labeledapopulationofpreexisting
unipotent luminal stem or long-lived progenitor cells
committed to the alveolar fate, and intraductal injection
ofWap-Cre adenovirus intoEN/+ females led to the develop-
ment of type 1 and type 2 mammary tumors identical to
those inWap-Cre;EN females (M.P.A.v.B., L.T., and Z.L., un-
publisheddata).AsK8 is apan-luminalmarker,Ad-K8-nlsCre
is expected to mark not only Wap-Cre-labeled alveolar
luminal stem/progenitor cells but also other luminal cell
types. Thus, our Ad-Cre-based tumor study suggests that
ENoncoprotein is capable of transformingmultiple luminal
MEC subsets. Furthermore, due to the short latency of EN-
induced mammary tumorigenesis (Figure 4A), our data are
consistent with a model in which multiple subpopulations
of luminal cells can serve as cells of origin, and distinct
cellular origins contribute to the heterogeneity of breast
cancer.EXPERIMENTAL PROCEDURES
Adenovirus Shuttle Vector Construction and
Adenovirus Production
Ad-CMV-Cre, Ad-CMV-GFP, promoterless adenoviral shuttle vector
(pacAd5 K-NpA), and the packaging vector [pAd5(9.2-100)sub360]es
ding mature luminal cells (ML) and luminal progenitors (LP), 3 days
s (Ba, including MaSC) 3 days (a–d) and 1.5 months (e–h) after
4-nlsCre.
upon pulse labeling by Ad-Cre injection at the nulliparous stage.
d YFP+ cells contributed to alveolar formation.
re-induced YFP+ cells contributed to alveolar myoepithelial cells (F)
ced by Ad-K14-nlsCre subdivided based on K8 and K14 expression
d clones.
m Cell Reports j Vol. 2 j 770–779 j June 3, 2014 j ª2014 The Authors 775
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Figure 4. Tumor Induction Using the Ad-
Cre Approach
(A) Kaplan-Meier curves showing mammary
tumor development in EN knockin virgin
female mice injected with Ad-K8-nlsCre
(n = 9) and in Wap-Cre;EN virgin females
(n = 10). All mice were under the pure FVB
background.
(B) Cre-mediated activation of the EN
conditional knockin allele in tumor cells
was confirmed by PCR. The locations of
the primers used to detect unexcised
and excised EN alleles are indicated in
Figure S4A.
(C) Three types of tumor derived from EN/+
mice injected with Ad-K8-nlsCre as revealed
by K8 and K14 IF staining. Scale bars,
50 mm.
See also Figure S4.
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of Iowa (Anderson et al., 2000). nlsCre was amplified from
pHR-CMV-nlsCRE plasmid (Addgene). Mouse K8 promoter was
amplified from mouse genomic DNA. Human K14 promoter was
amplified from K14-luciferase plasmid (Sugihara et al., 2001).
Crude Ad-K8-nlsCre and Ad-K14-nlsCre were purified using the
Adenopure purification kit (Puresyn).Mice
R26YFP and MMTV-Cre mice were purchased from The Jackson
Laboratory. K14-Cre and Wap-Cre mice were obtained from the
MMHCC Repository. Etv6-NTRK3 (EN) conditional knockin mice,
as well as Irs1 and Irs2 conditional knockout mice, were described
previously (Guo et al., 2009; Li et al., 2007). Adenoviruses were
introduced into their mammary ducts via intraductal injection.
All studies involving mice were approved by our institutional ani-Figure 3. IRS1 and IRS2 Are Essential for Maintaining the Basal L
(A and B) Bar graphs showing the percentages of YFP+ cells. Irs1L/L;I
injected with Ad-K8-nlsCre (A) or Ad-K14-nlsCre (B), and YFP+ cells were
were reported as mean ± SEM. n.s., not significant.
(C) Flow-cytometric analysis of YFP+ cells in Irs1L/L;Irs2L/L;R26YFP an
Ad-K14-nlsCre (i–p). Both luminal cells (compare f and h) and basal/m
after Ad-Cre injection. In particular, in Ad-K14-nlsCre injection group (c
much more profound than that in YFP+ luminal cells.
See also Figure S3.
Stemal care and use committee, and performed in accordance with
the relevant protocol.
MEC Preparation, Flow Cytometry, and Sorting
Single-cell suspensions of MECs were prepared as previously
described (Shackleton et al., 2006). After antibody staining, flow-
cytometric analysis was performed on Accuri 6 and DXP11 flow
cytometers. Cell sorting was performed on a BD Aria.
Immunostaining and Clonal Analysis
Mammary tissues were fixed in 10% buffered formalin (Fisher),
embedded in paraffin, and sectioned. IF and immunohistochem-
istry staining were performed on 6 mm paraffin sections for the
indicated antibodies by standard procedures. Clonal analysis was
performed on MG sagittal sections stained with YFP, K8, and K14
antibodies.ineage
rs2L/L;R26YFP (IRS-KO) and R26YFP-only (WT) control females were
measured by flow cytometry 3 days or 3 weeks after injection. Data
d R26YFP-only control females injected with Ad-K8-nlsCre (a–h) or
yoepithelial cells (compare n and p) decreased significantly 3 weeks
ompare n and p), the decrease in YFP+ basal/myoepithelial cells was
m Cell Reports j Vol. 2 j 770–779 j June 3, 2014 j ª2014 The Authors 777
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A Student’s t test was used for statistical analysis. Data were re-
ported as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental
Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.stemcr.2014.04.004.
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